Stable formulations for parenteral injection of peptide drugs

Leuprolide injection

Process for the synchronization of ovulation for timed breeding without heat detection

Method of treating prostate cancer with GnRH antagonist

DEVICES AND METHODS FOR TREATING AND/OR PREVENTING DISEASES

Softgel of NLKJ for treating prostate diseases

LEUPROLIDE INJECTION

Process for the manufacture of Degarelix and its intermediates

Treatment of prostate carcinoma

GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Recovery and processing of human embryos formed in vivo

Pharmaceutical composition containing goserelin for in-situ implant

Methods of administering an aromatase inhibitor, prostaglandin and GnRH for regulating ovulation in cattle

Implant cannula having an implant and a method for securing implants in an injection cannula

Process for the synchronization of ovulation for timed breeding without heat detection

Uses of Noscapine and Derivatives in Subjects Diagnosed with FAP

Process for the synchronization of ovulation for timed breeding without heat detection

Solvent/polymer solutions as suspension vehicles

Sustained delivery of an active agent using an implantable system

Bile Acid Recycling Inhibitors for Treatment of Pancreatitis

Solvent/polymer solutions as suspension vehicles

Method of treating prostate cancer with GnRH antagonist

Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses

TREATMENT WITH ANTI-VEGF ANTIBODIES

Immunogenic LHRH compositions and methods relating thereto

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

SUSTAINED-RELEASE COMPOSITION AND PROCESS FOR PRODUCING THE SAME

ACTIVE SELF-HEALING BIOMATERIAL SYSTEM

Controlled release composition and method of producing the same

Solvent/polymer solutions as suspension vehicles

Transdermal therapeutic system for the administration of peptides

Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3

Stable formulations for parenteral injection of peptide drugs

Long term drug delivery devices with polyurethane-based polymers and their manufacture

Sustained release formulations comprising GNRH analogues

METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS

COMPOSITION FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA

THERAPEUTIC CALCIUM PHOSPHATE PARTICLES AND METHODS OF MAKING AND USING SAME

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

COMPOSITIONS AND METHODS FOR TREATING PRECOCIOUS PUBERTY

Pharmaceutical compositions and related methods of delivery

BRAIN-DERIVED GONADOTROPINS AND COGNITION

METHOD FOR THE PROPHYLAXIS OR TREATMENT OF FLUSHING

Method and composition for synchronizing time of insemination

Pharmaceutical compositions and related methods of delivery

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INDUCTION AND ENHANCEMENT OF APOPTOSIS IN TUMOR CELLS

Sustained release of microcrystalline peptide suspensions

LHRH—antagonists in the treatment of fertility disorders

IMMUNOGENIC LHRH COMPOSITIONS AND METHODS RELATING THERETO

METHODS FOR TREATING AND PREVENTING CANCERS THAT EXPRESS THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS OF HORMONES AND RECEPTORS

DEVICES AND METHODS FOR TREATING AND/OR PREVENTING DISEASES

Solvent/polymer solutions as suspension vehicles

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen

IMPLANTABLE DEVICE FOR THE DELIVERY OF HISTRELIN AND METHODS OF USE THEREOF

Sustained delivery of an active agent using an implantable system

Quinazolinone Compounds and Methods of Use Thereof

TREATMENT OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT USING GNRH-I ANALOGS AND ONE OR MORE OF ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONISTS

Long term drug delivery devices with polyurethane-based polymers and their manufacture

Controlled release composition and method of producing the same

NANOPARTICULATE BICALUTAMIDE FORMULATIONS

Implant devices that differ by release profile and methods of making and using same

COMPOSITIONS AND METHODS FOR ORAL DRUG DELIVERY

METHOD AND MEANS FOR TREATING VIRAL DISEASE, IN PARTICULAR HIV/AIDS

TREATMENT WITH ANTI-VEGF ANTIBODIES

Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles

Residual solvent extraction method and microparticles produced thereby

PHARMACOPERONES FOR CORRECTING DISEASE STATES INVOLVING PROTEIN MISFOLDING

THE USE OF GNRH ANTAGONIST PEPTIDE IN THE TREATEMENT OF SEX HORMONE-DEPENDENT DISEASES

Slow release pharmaceutical composition made of microgranules

COMPOSITIONS, KITS AND METHODS FOR TREATING BENIGN PROSTATE HYPERPLASIA

Compositions comprising GHRH and GnRH and methods of using the same

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

USE OF BETA-MELANOTROPIN AS A THERAPEUTIC AGENT, EG FOR THE TREATMENT OF AIDS OR ALZHEIMER

Pharmaceutical compositions and methods for the treatment of prostate cancer

SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES

USE OF SALUSIN BETA ALONE OR IN COMBINATION WITH OCTREOTIDE AS A THERAPEUTIC AGENT

METHODS FOR SLOWING SENESCENCE AND TREATING AND PREVENTING DISEASES ASSOCIATED WITH SENESCENCE

USE OF CNP-22, ALONE OR IN COMBINATION WITH PHYSALEMIN, AS A THERAPEUTIC AGENT

SUSTAINED RELEASE OF MICROCRYSTALLINE PEPTIDE SUSPENSIONS

Polymeric delivery formulations of leuprolide with improved efficacy

Polymeric delivery formulations of leuprolide with improved efficacy

TREATMENT WITH ANTI-VEGF ANTIBODIES

USE OF IL-1 RECEPTOR PEPTIDE, ALONE OR IN COMBINATION WITH D-ALA-GLN-OCTADECYL ESTER, AS A THERAPEUTIC AGENT

MINIGASTRIN AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

THERAPEUTIC USES OF INTERMEDIN 47 AND 53 PEPTIDES

USE OF LEPTIN (22-56 ) AS A THERAPEUTIC AGENT

Sustained release formulations comprising very low molecular weight polymers

Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women

Use of Gonadorelin as a therapeutic agent

USE OF C-TYPE NATRIURETIC PEPTIDE, ALONE OR IN COMBINATION WITH NEUROPEPTIDE AF, AS A THERAPEUTIC AGENT

USE OF NEUROTROPHIC FACTOR FOR RETINAL CHOLINERGIC NEURONS (NFRCN) AND CHORIONIC GONADOTROPIN-BETA (109-145) AS THERAPEUTIC AGENTS

USE OF URODILATIN AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF MELANIN CONCENTRATING HORMONE AND MET-ENKEPHALIN AS THERAPEUTIC AGENTS

METHODS FOR REDUCING GNRH-POSITIVE TUMOR CELL PROLIFERATION

USE OF THE HUMAN PANCREATIC POLYPEPTIDE AS A THERAPEUTIC AGENT

USE OF FERTIRELIN AND DELTA-ENDORPHIN AS THERAPEUTIC AGENTS

RESCUE OF GONADOTROPIN RELEASING HORMONE RECEPTOR MUTANTS

Solid drug formulation and device for storage and controlled delivery thereof

Sustained delivery of an active agent using an implantable system

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

Non-polymeric compositions for controlled drug delivery

BRAIN-DERIVED GONADOTROPINS AND COGNITION

METHODS FOR THE MODULATION OF BRAIN PROGESTAGEN SIGNALING IN THE PREVENTION AND TREATMENT OF NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES

BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME

COMBINATION COMPRISING N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-(1,3,4-OXADIAZOL-2-YL)PHENYL) PYRIDINE-3-SULPHONAMIDE AND AN LHRH ANALOGUE AND/OR A BISPHOSPHONATE

Injectable delivery of microparticles and compositions therefore

Controlled release copolymer formulation with improved release kinetics

NANOPARTICULATE BICALUTAMIDE FORMULATIONS

Immunogenic LHRH compositions and methods relating thereto

Compositions of GnRH related compounds and processes of preparation

Compositions of peptides and processes of preparation thereof

Methods and devices for the sustained release of multiple drugs

Process of preparing microspheres for sustained release having improved dispersibility and syringeability

GNRH ANALOGUES FOR TREATMENT OF URINARY INCONTINENCE

TREATMENT WITH ANTI-VEGF ANTIBODIES

HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS

Immunogenic LHRH compositions and methods relating thereto

METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

Method of treating metastatic stage prostate cancer

Methods for treating FSH related conditions with GnRH antagonists

Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors

Residual solvent extraction method and microparticles produced thereby

Treatment with anti-VEGF Antibodies

IGF-IR antagonists as adjuvants for treatment of prostate cancer

Pharmaceutical Combinations of Diazole Derivatives for Cancer Treatment

Hormone normalization therapy comprising administration of aromatase inhibitor, follicle stimulating hormone, luteinizing hormone, human chorionic gonadotropin, gonadotropin hormone releasing hormone and/or progesterone

SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS

Biodegradable implants with controlled bulk density

Long term drug delivery devices with polyurethane based polymers and their manufacture

LHRH ANTAGONISTS FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS

METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS

Treatment with Anti-VEGF Antibodies

Sustained-release preparation

INCREASING PREGNANCY RATES

Gynecological pharmaceutics- containing microspherical vascular suppository of sodium alginate and its preparation method

Use of a GnRH antagonist peptide in the treatment of sex hormone-dependent diseases

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

Controlled release composition and method of producing the same

Polymeric device for controlled release of active agents

Polymeric devices for controlled release of active agents

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS

Methods and devices for the sustained release of multiple drugs

Therapy of Prostate Cancer With Ctla-4 Antibodies and Hormonal Therapy

Treatment With Anti-VEGF Antibodies

Disease Prevention and Vaccination Prior to Thymic Reactivation

TREATMENT WITH ANTI-VEGF ANTIBODIES

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH A LUTEIN-HORMONE-RELEASING HORMONE AGONIST AND ANTAGONIST FOR USE IN BRCA MEDIATED DISEASES

Sterile suspensions of slightly soluble basic peptide complexes and pharmaceutical formulations containing them

PARTICULATE DRUG DELIVERY

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

Methods and devices for the sustained release of multiple drugs

Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation

TREATMENT WITH ANTI-VEGF ANTIBODIES

Leuprolide acetate and acetylcholinesterase inhibitors/NMDA receptor antagonists for the treatment of alzheimer's disease

INHIBITORS OF PHOSPHODIESTERASES IN INFERTILITY

MEDICINAL PREPARATIONS FOR TREATING SEX HORMONE-DEPENDENT DISEASES

Combination Comprising Zd6474 And An Antiandrogen

Treatment of cancer by a combination of non-ionizing radiation and androgen deprivation

Combination Treatment Methods

Sustained release polymer

Controlled release compositions

Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

Sustained-release composition and process for producing the same

COMPOSITIONS AND METHODS FOR TREATING DISEASES THROUGH INHIBITION OF DNA METHYLATION AND HISTONE DEACETYLASE

SARMS and method of use thereof

Residual solvent extraction method and microparticles produced thereby

Residual solvent extraction method and microparticles produced thereby

Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits

Treating sex steriod responsive disorders

Use of Il-17 in the Treatment of Fertility-Related Disorders

Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parenteral administration and preparation process

Regulation of Sperm Function

Preparation Method for Sustained Release Microspheres Using a Dual-Feed Nozzle

Tolerance to Graft Prior to Thymic Reactivation

Use of GPCR54 Ligands for the Treatment of Infertility

Process of preparing microspheres for sustained release having improved dispersibility and syringeability

Lactic acid polymer and process for producing the same

Treatment with anti-VEGF antibodies

Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers

Methods for treating prostate cancer

Enhancement of Endogenous Gonadotropin Production

2-METHYLTHIAZOLIDINE-2, 4-DICARBOXYLIC ACID-CONTAINING COMBINATION PREPARATIONS

Process for the synchronization of ovulation for timed breeding without heat detection

Residual solvent extraction method and microparticles produced thereby

Methods and devices for the sustained release of multiple drugs

Pharmaceutical compositions with enhanced stability

Short interfering RNA (siRNA) analogues

Pharmaceutical formulations for sustained drug delivery

Pharmaceutical formulations for sustained drug delivery

Methods for slowing senescence and treating and preventiing diseases associated with senescence

PROCESS FOR THE SYNCHRONIZATION OF OVULATION FOR TIMED BREEDING WITHOUT HEAT DETECTION

Compositions capable of facilitation penetration across a biological barrier

Injection solution of an LHRH antagonist

TREATMENT WITH ANTI-VEGF ANTIBODIES

Treatment of cancer by a combination of non-ionizing radiation and androgen deprivation

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

Polymeric delivery formulations of leuprolide with improved efficacy

Controlled release compositions

Liposomal vaccine

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators

Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels

Liposomal vaccine

Methods and compositions using gonadotropin hormone releasing hormone

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

Long-acting solid formulation comprising triptorelin acetate

TREATMENT WITH ANTI-VEGF ANTIBODIES

TREATMENT WITH ANTI-VEGF ANTIBODIES

Methods for treating FSH related conditions with GnRH antagonists

Methods for treating prostate cancer

Encapsulation of water soluble peptides

Combination comprising N-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazol-2-y1]pyridine-3-sulphonamide and an lhrh analogue and/or bisphosphonate

Process for the synchronization of ovulation for timed breeding without heat detection

Bioabsorbable pharmaceutical formulation

Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors

INHIBITORS OF PHOSPHODIESTERASES IN INFERTILITY

Treatment of T cell disorders

Sustained release of microcrystalline peptide suspensions

Sustained release of microcrystalline peptide suspensions

Method for the treatment of prostate cancer

Solvent/polymer solutions as suspension vehicles

Treatment of T cell disorders

Agents for preventing postoperative recurrence of premenopausal breast cancer

Nanoparticulate bicalutamide formulations

Methods for treating and preventing brain cancers

Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease

Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer

Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments

Lactic acid polymer and process for producing the same

Phosphorylated polymers and conjugates thereof

Long-acting gonadotropin-releasing hormone analogs and methods of use thereof

Residual solvent extraction method and microparticles produced thereby

Pharmaceutical compositions for sustained drug delivery

Hydroxide-releasing agents as skin permeation enhancers

Treatment of T cell disorders

Use of inhibitors of 24-hydroxylase in the treatment of cancer

Use of GnRH agonists to support the luteal phase during infertility treatment

Methods for screening, studying, and treating dissorders with a component of mercurial toxicity

Methods of treating disorders having a component of mercury toxicity

Methods for treating premature infants

Process for the production of implants

Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy

Compositions suitable for controlled release of the hormone GnRH and its analogs

Immunogenic LHRH compositions and methods relating thereto

Compositions and methods for treating precocious puberty

Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer

Slow release protein polymers

Polymeric devices for controlled release of active agents

Lactone bearing absorbable polymers

Gonadotropin releasing hormone antagonists in gel-forming concentrations

Compositions and methods to inhibit restenosis

Transient and/or permanent modification of sexual behavior and/or fertility using recombinant chimeric GnRH

Methods for treating long QT syndrome

Process for producing sustained-release composition

Method for pharmacoperones correction of GnRHR mutant protein misfolding

Treatment with anti-VEGF antibodies

Liposomal vaccine

Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase

Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasation

Process for the synchronization of ovulation for timed breeding without heat detection

Oligopeptide lyophilisate, their preparation and use

Anticancer agents

Method of treating breast cancer

Polytartrate composition

Composition and apparatus for transdermal delivery

Intranasal administration of polypeptides in powdered form

Residual solvent extraction method and microparticles produced thereby

Stabilized reverse micelle compositions and uses thereof

Compositions and methods for treating ileus

LHRH-antagonists in the treatment of fertility disorders

Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions

Sustained release compositions, process for producing the same and utilization thereof

Biodegradable implant comprising a polylactide polymer and a lh-rh analogue

Method for ameliorating or avoiding the adverse effects of exogenous gonadotropins on reproductive performance

Method and kit for home controlled ovarian stimulation for in vitro fertilization